A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults
Background. A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | International Journal of Hypertension |
| Online Access: | http://dx.doi.org/10.1155/2018/3934296 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832563205102108672 |
|---|---|
| author | R. Bou Serhal P. Salameh N. Wakim C. Issa B. Kassem L. Abou Jaoude N. Saleh |
| author_facet | R. Bou Serhal P. Salameh N. Wakim C. Issa B. Kassem L. Abou Jaoude N. Saleh |
| author_sort | R. Bou Serhal |
| collection | DOAJ |
| description | Background. A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared to MMAS-8, and to assess adherence rates and factors. Methodology. A cross-sectional study, including 405 patients, was performed in outpatient cardiology clinics of three hospitals in Beirut. Blood pressure was measured, a questionnaire filled, and sodium intake estimated by a urine test. Logistic regression defined predictors of hypertension control and adherence. Results. 54.9% had controlled hypertension. 82.4% were adherent by the new scale, which showed good internal consistency, adequate questions (KMO coefficient = 0.743), and four factors. It predicted hypertension control (OR = 1.217; p value = 0.003), unlike MMAS-8, but the scores were correlated (ICC average measure = 0.651; p value < 0.001). Stress and smoking predicted nonadherence. Conclusion. This study elaborated a validated, practical, and useful tool measuring adherence to medications in Lebanese hypertensive patients. |
| format | Article |
| id | doaj-art-21647787530f49e796810232275366bb |
| institution | Kabale University |
| issn | 2090-0384 2090-0392 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Hypertension |
| spelling | doaj-art-21647787530f49e796810232275366bb2025-02-03T01:20:38ZengWileyInternational Journal of Hypertension2090-03842090-03922018-01-01201810.1155/2018/39342963934296A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive AdultsR. Bou Serhal0P. Salameh1N. Wakim2C. Issa3B. Kassem4L. Abou Jaoude5N. Saleh6Department of Epidemiology and biostatistics, Faculty of Public Health, Lebanese University, Fanar, LebanonFaculty of Pharmacy, Lebanese University, Al Hadath, LebanonDepartment of Epidemiology and biostatistics, Faculty of Public Health, Lebanese University, Fanar, LebanonDepartment of Nutrition and Dietetics, Faculty of Public Health, Lebanese University, Fanar, LebanonDepartment of Epidemiology and biostatistics, Faculty of Public Health, Lebanese University, Fanar, LebanonDepartment of Epidemiology and biostatistics, Faculty of Public Health, Lebanese University, Fanar, LebanonDepartment of Epidemiology and biostatistics, Faculty of Public Health, Lebanese University, Fanar, LebanonBackground. A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared to MMAS-8, and to assess adherence rates and factors. Methodology. A cross-sectional study, including 405 patients, was performed in outpatient cardiology clinics of three hospitals in Beirut. Blood pressure was measured, a questionnaire filled, and sodium intake estimated by a urine test. Logistic regression defined predictors of hypertension control and adherence. Results. 54.9% had controlled hypertension. 82.4% were adherent by the new scale, which showed good internal consistency, adequate questions (KMO coefficient = 0.743), and four factors. It predicted hypertension control (OR = 1.217; p value = 0.003), unlike MMAS-8, but the scores were correlated (ICC average measure = 0.651; p value < 0.001). Stress and smoking predicted nonadherence. Conclusion. This study elaborated a validated, practical, and useful tool measuring adherence to medications in Lebanese hypertensive patients.http://dx.doi.org/10.1155/2018/3934296 |
| spellingShingle | R. Bou Serhal P. Salameh N. Wakim C. Issa B. Kassem L. Abou Jaoude N. Saleh A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults International Journal of Hypertension |
| title | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
| title_full | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
| title_fullStr | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
| title_full_unstemmed | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
| title_short | A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults |
| title_sort | new lebanese medication adherence scale validation in lebanese hypertensive adults |
| url | http://dx.doi.org/10.1155/2018/3934296 |
| work_keys_str_mv | AT rbouserhal anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT psalameh anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT nwakim anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT cissa anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT bkassem anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT laboujaoude anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT nsaleh anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT rbouserhal newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT psalameh newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT nwakim newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT cissa newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT bkassem newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT laboujaoude newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults AT nsaleh newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults |